13F Data
13F filer · CIK 1974915

Vestal Point Capital, LP

NEW YORK, NY · filing since Q4 2023 · last filing Aug 14, 2026
Reported value
$4.3B
+$702.6M vs prior
Positions
68
New / sold out
11 / 33
Added / reduced
31 / 21
Turnover
39.4%
buys $1.6B · sells $1.5B
Top-10 weight
50.3%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
AddedUnited Therapeutics Corp+360,000+480.0%+$195.1M
AddedBioMarin Pharmaceutical Inc+2,450,000+68.5%+$140.2M
NewAbbott Laboratories+1,400,000–+$127.0M
AddedAbivax SA+849,443+56.6%+$113.2M
AddedNeurocrine Biosciences Inc+630,000+50.4%+$106.2M
AddedZimmer Biomet Holdings Inc+1,210,000+636.8%+$104.2M
NewAscendis Pharma A/S+375,000–+$100.0M
AddedInsulet Corp+619,399+1224.1%+$94.3M
AddedAstraZeneca PLC+350,000+350.0%+$66.4M
AddedDisc Medicine Inc+850,000+121.4%+$62.2M
32 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
ReducedRevolution Medicines Inc-1,925,000-81.1%$-360.5M
Sold outApogee Therapeutics Inc-1,100,000-100.0%$-92.6M
Sold outAscendis Pharma A/S-375,000-100.0%$-85.8M
ReducedRepligen Corp-525,000-56.8%$-71.6M
Sold outScholar Rock Holding Corp-1,324,422-100.0%$-65.1M
ReducedArrowhead Pharmaceuticals Inc-700,000-30.8%$-57.1M
Sold outVera Therapeutics Inc-1,368,159-100.0%$-55.0M
Sold outTerns Pharmaceuticals Inc-1,000,000-100.0%$-52.7M
Sold outBoston Scientific Corp-800,000-100.0%$-50.2M
Sold outNuvalent Inc-481,715-100.0%$-49.4M
44 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2023: $944.0MQ1 2024: $1.2BQ2 2024: $1.3BQ3 2024: $1.3BQ4 2024: $1.7BQ1 2025: $1.4BQ2 2025: $1.9BQ3 2025: $2.2BQ4 2025: $2.9BQ1 2026: $3.6BQ2 2026: $4.3B
Q4 2023Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1BioMarin Pharmaceutical IncCOM6,025,000$344.8M8.06%
2Neurocrine Biosciences IncCOM1,880,000$316.8M7.40%
3Abivax SASPONSORED ADS2,349,443$313.1M7.32%
4United Therapeutics CorpCOM435,000$235.7M5.51%
5Enliven Therapeutics IncCOM4,000,000$203.0M4.74%
6Nurix Therapeutics IncCOM8,050,000$195.3M4.56%
7Bicara Therapeutics IncCOM5,250,000$155.9M3.64%
8Taysha Gene Therapies IncCOM SHS19,415,000$132.2M3.09%
9Arrowhead Pharmaceuticals IncCOM1,575,000$128.4M3.00%
10Abbott LaboratoriesCOM1,400,000$127.0M2.97%
58 more rows. Subscribe for $29/month to see every row, download the data and use the API.